Castleview Partners’s MiMedx Group MDXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-270
| Closed | -$1.87K | – | 764 |
|
|
2024
Q2 | $1.87K | Hold |
270
| – | – | ﹤0.01% | 748 |
|
|
2024
Q1 | $2.08K | Hold |
270
| – | – | ﹤0.01% | 736 |
|
|
2023
Q4 | $2.37K | Hold |
270
| – | – | ﹤0.01% | 690 |
|
|
2023
Q3 | $1.97K | Sell |
270
-13,900
| -98% | -$101K | ﹤0.01% | 557 |
|
|
2023
Q2 | $93.7K | Hold |
14,170
| – | – | 0.08% | 192 |
|
|
2023
Q1 | $48.3K | Sell |
14,170
-2,000
| -12% | -$6.82K | 0.04% | 270 |
|
|
2022
Q4 | $45K | Hold |
16,170
| – | – | 0.04% | 240 |
|
|
2022
Q3 | $46K | Buy |
16,170
+13,103
| +427% | +$37.3K | 0.04% | 264 |
|
|
2022
Q2 | $78.5K | Sell |
3,067
-40,285
| -93% | -$1.03M | 0.06% | 238 |
|
|
2022
Q1 | $204K | Sell |
43,352
-212,242
| -83% | -$999K | 0.13% | 160 |
|
|
2021
Q4 | $42.3K | Buy |
+255,594
| New | +$42.3K | 0.34% | 30 |
|
|
2021
Q2 | $677K | Buy |
+54,083
| New | +$677K | 0.3% | 71 |
|
|
2018
Q1 | $389K | Buy |
+55,743
| New | +$389K | 0.32% | 74 |
|